
Written based on 4 research studies on PubMed, searched on 2026. nov. 11..
The claim
Posts online say that fenbendazole helps with ovarian cancer.
Where research stands
We found 4 published papers on fenbendazole and ovarian cancer. They were published between 2023 and 2026. None of them is a study in people. 2 were studies in animals, and 2 were only in cells in the lab.
- 0In people
- 2In animals
- 2Only in the lab
What the studies found
We have not summed up these studies in words yet. The most important papers are listed under Sources.
Verdict
Fenbendazole has been studied for ovarian cancer in animals, not yet in people.
Unproven means: it was only tested in animals or cells, or there is too little or mixed data from people. How we rate claims
What this means for you: Results in animals or in cells often do not hold in people. Do not stop or change your medicines because of it. Ask your doctor before you start taking it.
Sources
- Transcriptome analysis reveals the anticancer effects of fenbendazole on ovarian cancer: an in vitro and in vivo study.2024 · BMC Cancer · In animals
- Anti-cancer effect of fenbendazole-incorporated PLGA nanoparticles in ovarian cancer.2023 · J Gynecol Oncol · In animals
- Preferential toxicodynamic effects of fenbendazole in ovarian cancer and nonmalignant ovarian cell models.2026 · Drug Chem Toxicol · In the lab
- Anticancer Evaluation of Methoxy Poly(Ethylene Glycol)-b-Poly(Caprolactone) Polymeric Micelles Encapsulating Fenbendazole and Rapamycin in Ovarian Cancer.2023 · Int J Nanomedicine · In the lab


